2013 Red Cells Gordon Research Conference & Gordon Research Seminar

2013 红细胞戈登研究会议

基本信息

  • 批准号:
    8525933
  • 负责人:
  • 金额:
    $ 1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-04-01 至 2014-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The 2013 Red Cells Gordon Research Conference and Gordon Research Seminar (GRC/GRS) is the next in a series of meetings that have been held every other year since 1979. This conference, with its rich history and engaged community, will assemble not only established investigators and the most promising new researchers, but also the next generation of trainees who are working on all aspects of erythroid cells, from the developmental control of its ontogeny, to cellular-morphogenic aspects of its unique membrane structure, to transcriptional and epigenetic regulation of its gene expression, to regulation of irn and heme metabolism, and to disorders following from variations in these normal processes. The Red Cells GRC continues to be the primary venue for presentation of the latest, cutting-edge basic science, novel insights into human disease, and innovations in methodology that it has covered throughout its history and for which it has become famous. We also proposed and were approved to hold a Red Cells GRS to foster trainee interactions and provide a forum of scientific exchange and career mentorship. These combined GRS/GRC meetings will attract an international coterie of researchers and provide a lively forum for active participation and discussion within intimate surroundings that facilitates interactions between senior and junior investigators, and between investigators that normally may not readily interact. The GRS and the GRC meetings will be held on July 6-7 and July 7-12, 2011, respectively, at Proctor Academy in Andover, New Hampshire. We will gather trainees to interact with senior mentors at the GRS. We will also convene a total of 52 speakers with a total of approximately 140 participants for the GRC, inclusive with respect to gender, ethnicity and persons with disabilities The opportunities for informal gatherings at meals, and in the afternoons and evenings, provides an avenue for scientists from different disciplines to interact, promoting cross-disciplinary collaboration. By the nature of their subject matter, the Red Cells GRS and GRC remain fully relevant to enhancing the understanding of both the normal progression of erythroid cell maturation and the alterations that lead to its pathology.
描述(申请人提供):2013年红血球戈登研究会议和戈登研究研讨会(GRC/GRS)是自1979年以来每隔一年举行的一系列会议中的下一次。这次会议,凭借其丰富的历史和积极的社区,不仅将聚集成熟的研究人员和最有前途的新研究人员,而且还将聚集下一代受训人员,他们致力于红系细胞的各个方面,从其个体发育的发育控制,到其独特的膜结构的细胞形态发生方面,到其基因表达的转录和表观遗传调节,到IRN和血红素代谢的调节,以及由于这些正常过程的变化而导致的疾病。红血球GRC仍然是展示最新的尖端基础科学、对人类疾病的新颖见解和方法论创新的主要场所,它涵盖了整个历史,并因此而闻名。我们还提议并被批准举办红血球GRS,以促进学员的互动,并提供一个科学交流和职业指导的论坛。这些联合的GRS/GRC会议将吸引国际研究人员的小圈子,并提供一个活跃的论坛,在亲密的环境中积极参与和讨论,促进高级和初级调查人员之间的互动,以及通常不容易互动的调查人员之间的互动。GRS和GRC会议将分别于2011年7月6日至7日和7月7日至12日在新罕布夏州安多弗的普罗科特学院举行。我们将召集学员与GRS的高级导师进行互动。我们还将为GRC召集总共52位演讲者,总共约140名参与者,包括性别、种族和残疾人在内,我们将为GRC提供在用餐、下午和晚上举行非正式聚会的机会,为来自不同学科的科学家提供交流的渠道,促进跨学科合作。根据其主题的性质,红细胞GRS和GRC仍然与增强对红系细胞成熟的正常进程和导致其病理的变化的理解完全相关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James Palis其他文献

James Palis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James Palis', 18)}}的其他基金

Embryonic natural killer cell development and function
胚胎自然杀伤细胞的发育和功能
  • 批准号:
    10661496
  • 财政年份:
    2021
  • 资助金额:
    $ 1万
  • 项目类别:
Embryonic natural killer cell development and function
胚胎自然杀伤细胞的发育和功能
  • 批准号:
    10328573
  • 财政年份:
    2021
  • 资助金额:
    $ 1万
  • 项目类别:
Megakaryocyte and platelet ontogeny
巨核细胞和血小板个体发育
  • 批准号:
    8829970
  • 财政年份:
    2013
  • 资助金额:
    $ 1万
  • 项目类别:
Megakaryocyte and platelet ontogeny
巨核细胞和血小板个体发育
  • 批准号:
    8694029
  • 财政年份:
    2013
  • 资助金额:
    $ 1万
  • 项目类别:
Megakaryocyte and platelet ontogeny
巨核细胞和血小板个体发育
  • 批准号:
    9043868
  • 财政年份:
    2013
  • 资助金额:
    $ 1万
  • 项目类别:
Megakaryocyte and platelet ontogeny
巨核细胞和血小板个体发育
  • 批准号:
    8478982
  • 财政年份:
    2013
  • 资助金额:
    $ 1万
  • 项目类别:
Megakaryocyte and platelet ontogeny
巨核细胞和血小板个体发育
  • 批准号:
    9264520
  • 财政年份:
    2013
  • 资助金额:
    $ 1万
  • 项目类别:
Role of EPO in terminal erythroid maturation
EPO 在终末红细胞成熟中的作用
  • 批准号:
    8685321
  • 财政年份:
    2012
  • 资助金额:
    $ 1万
  • 项目类别:
Role of EPO in terminal erythroid maturation
EPO 在终末红细胞成熟中的作用
  • 批准号:
    8875051
  • 财政年份:
    2012
  • 资助金额:
    $ 1万
  • 项目类别:
Role of EPO in terminal erythroid maturation
EPO 在终末红细胞成熟中的作用
  • 批准号:
    8417125
  • 财政年份:
    2012
  • 资助金额:
    $ 1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了